Anavex Life Sciences Corp
Price
FilingsNewest: 8-K, Change in controlSep 28 →InsidersNo open-market buys or sales.→HoldersBlackRock 8.7%Vanguard 4.4%Two Sigma Investments 3.3%→Financing →PeersClosest companies: BNTC, SKYX, IMMX→
From the filings
Figures
- Net income
- −$13.0Mlast 12 months
- Operating cash flow
- −$34.1Mlast 12 months
- Cash and equivalents
- $118.3Mat the last balance sheet
- Shares outstanding
- 92.7M shareson issue